Mark David Rackham
10Patents
8h-index
11Co-inventors
61Inventor score
Filing activity: Feb 6, 2015 → Jun 17, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9670183B2 | Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists | Chemistry; Metallurgy | 30 | Active |
| US10196380B2 | Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor agonists | Chemistry; Metallurgy | 16 | Active |
| US9926297B2 | Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists | Chemistry; Metallurgy | 15 | Active |
| US10385039B2 | Bicyclic aza compounds as muscarnic M1 receptor and/or M4 receptor antagonists | Chemistry; Metallurgy | 12 | Active |
| US10689368B2 | Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor | Chemistry; Metallurgy | 11 | Active |
| US10961225B2 | Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor | Chemistry; Metallurgy | 10 | Active |
| US10548884B2 | Muscarinic agonists | Chemistry; Metallurgy | 10 | Active |
| US11324738B2 | Muscarinic agonists | Chemistry; Metallurgy | 9 | Active |
| US10435391B2 | Compounds | Chemistry; Metallurgy | 1 | Active |
| US10781205B2 | Conjugates comprising RIPK2 inhibitors | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.